$4.32 $0.03 (0.7%)

12:44 PM EST on 11/14/19

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)

CAPS Rating: 3 out of 5

Current Price $4.32 Mkt Cap $277.4M
Open $4.25 P/E Ratio 0.00
Prev. Close $4.29 Div. (Yield) $0.00 (0.0%)
Daily Range $4.18 - $4.35 Volume 747,457
52-Wk Range $4.18 - $9.11 Avg. Daily Vol. 608,081

Caps

How do you think NASDAQ:CRBP will perform against the market?

Add Stock to CAPS Watchlist

All Players

30 Outperform
5 Underperform
 

All-Star Players

4 Outperform
1 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NASDAQ:CRBP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:CRBP VS S&P 500 (SPY)

NASDAQ:CRBP Summary

Fools bullish on NASDAQ:CRBP are also bullish on:

Fools bearish on NASDAQ:CRBP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CRBP.

Recs

0
Member Avatar rick16 (37.05) Submitted: 2/22/2019 4:01:31 PM : Outperform Start Price: $8.72 NASDAQ:CRBP Score: -60.37

Going to be a top performer in the CBD market

Recs

0
Member Avatar andersonstair (< 20) Submitted: 12/28/2017 7:54:17 PM : Outperform Start Price: $7.58 NASDAQ:CRBP Score: -57.22

Oh Canada!!
The whole sector will continue to burn red hot as july 1st approaches ....

Recs

0
Member Avatar davard070401 (74.28) Submitted: 11/23/2016 3:39:00 PM : Outperform Start Price: $7.58 NASDAQ:CRBP Score: -57.22

Corbus is an extremely speculative, tiny biotech firm. Their new drug, Resunab, recently completed phase 2 trials successfully, so it has a very long journey to profitability. The drug is intended to treat chronically activated immune systems. One example target of Resunab is cystic fibrosis. A simplified description of its action is that when the immune system is stuck in overdrive, Resunab is the reset switch. That reset of the immune system directly cures diseases such as lupus and cystic fibrosis, but, again, the efficacy will not be proven for a very long time.

Leaderboard

Find the members with the highest scoring picks in CRBP.

Score Leader

t0bes

t0bes (< 20) Score: +57.22

The Score Leader is the player with the highest score across all their picks in CRBP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
t0bes < 20 2/1/2019 Underperform 5Y $7.58 -43.00% +14.22% +57.22 0 Comment
GabrielSevrs 30.89 2/1/2019 Underperform 3W $7.58 -43.00% +14.22% +57.22 0 Comment
OttoBismarck 99.94 2/1/2019 Underperform 5Y $7.58 -43.00% +14.22% +57.22 0 Comment
luh < 20 2/1/2019 Underperform 3Y $7.58 -43.00% +14.22% +57.22 0 Comment
sharktrade < 20 8/16/2019 Underperform 5Y $5.50 -21.45% +7.65% +29.09 0 Comment
Playa14 < 20 11/12/2019 Outperform 5Y $4.56 -5.25% -0.04% -5.22 0 Comment
pannikin < 20 11/11/2019 Outperform 5Y $4.56 -5.25% +0.37% -5.63 0 Comment
foolarooskie 31.67 10/17/2019 Outperform 5Y $4.82 -10.37% +2.97% -13.34 0 Comment
Under5 < 20 10/2/2019 Outperform 5Y $4.87 -11.19% +6.98% -18.17 0 Comment
TraderEnvy < 20 10/4/2019 Outperform 5Y $5.04 -14.28% +5.93% -20.21 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRBP.